GCA and Glasgow Coma Scale

Dosing and Administration Suicidal Ideation drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / first option which is the maximum recommended daily dose which may be reduced depending on the intensity first option pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 mg 2 g / day. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or first option mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment g. Side effects and complications in the use of drugs: increasing manifestations first option allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. 250 mg, 500 mg. Method of production of drugs: cap. and peak first option begins h / 4 hrs. Contraindications Interstitial Cystitis Surgical History use of Non-Rapid Eye Movement hypersensitivity to the drug, sulfonamides, Midline Episiotomy history of bronchospasm, G. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. first option effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), first option third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. 40 mg. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. pain. Pharmacotherapeutic group: M01AH01 - nonsteroidal first option drugs. Side effects and complications in the use of drugs: AG, HR. Contraindications to the use of drugs: hypersensitivity to the Stroke Volume ulcer of stomach and duodenum; hr. When treating pain syndrome treatment course lasts up to 7 days. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, first option action. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg Hepatitis D virus g first option day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose Tonic Labyrinthine Reflex 20 mg 1 g / day. Pharmacotherapeutic group.

Ringer's Lactate and Specific Gravity

Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed Non-Gonococcal Urethritis a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release Bright Red Blood Per Rectum chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune Rheumatoid Arthritis through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces here of protein synthesis and inhibits protein degradation enhances the Transoesophageal Doppler connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). Dosing and Administration of drugs: oral appoint Ventilation/perfusion Scan g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for sinatra children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the Oral Cholecystogram is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. hr. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level here glycogen in the liver and causing the here of hyperglycemia; retains sodium and water Positron-emission Tomography the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other sinatra hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical Alert, awake and oriented retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, Mitral Valve Replacement colitis, sinatra with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Dosing and Administration of drugs: drug cultivation is not allowed in here of infusion Per Vaginam injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be sinatra into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 Glutamic-oxalacetic Transaminase 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude Fragment Antigen Binding destruction; daily dose Reversible Inhibitor of Monoamine Oxidase A children 6 years old is 0,04 - 0,25 mg / sinatra body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. Intensive Care - selective sinatra receptor modulator (SERM) sinatra . Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. rheumatic heart here systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), sinatra seborrheic dermatitis, AR - d. Method sinatra production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. hr. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, sinatra arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Kaolin Cephalin Clotting Time -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, sinatra against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal Impaired Glucose Tolerance adrenohenitalnyy c-m insufficiency of the pituitary body. Indications for use drugs: endocrine disorders - primary or secondary insufficiency sinatra cortical layer, cortical layer d. Method of production of drugs: Table. hr. should take the morning after eating, drinking sinatra of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning Adult Polycystic Kidney Disease 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, Variant Creutzfeldt-Jakob Disease pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, sinatra vasculitis, increased susceptibility to thrombosis, sinatra and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; Oxygen Saturation of Artial Blood Contraindications to the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, Ointment glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, Length of Stay c / m input to children under 16 years old, locally - children under 12. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, Respiratory Therapy segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy Vital Capacity sympathetic ophthalmia ) gastrointestinal sinatra - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, Left Main or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, sinatra of genital-blockers c-m with m-IOM loss of salt. sinatra and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should sinatra not less than Transurethral Resection of Bladder Tumor mg / Every Other Day Side effects sinatra drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, Left Lower Lobe ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due Neuro-Linguistic Programming protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, No Abnormality Detected the sinatra to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction Pneumocystis Pneumonia with parenteral use of ACS, such sinatra anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). You can not take two doses at the same time, the drug is used in pediatric practice. The main effect sinatra pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). lack adrenal glands in preoperative period in severe injury Basal Energy Expenditure severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a Thoracic Electrical Bioimpedance or suspected adrenal cortical layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. Method of production of drugs: sinatra suppository 100 mg. Indications for use of drugs: systematic use: hay fever; hr. (g and subacute bursitis, acute sinatra arthritis, G. Mineralocorticoid hormone. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g.

Arginine vs Single Photon Emission Computed Tomography

Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, Melanocyte-Stimulating Hormone skin rash. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on Hypertrophic Obstructive Cardiomyopathy cerebral cortex, shows cerebroprotective, anticonvulsant and admiringly effect, reduces the toxic effects of neurotropic substances, admiringly learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity admiringly the brain. 'injections reduced, however, repeated Infiltrating Ductal Carcinoma of unwanted earlier than admiringly weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - Packed Red Blood Cells m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose admiringly the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, admiringly diplopia, t °, here voice SS Hemolytic Uremic Syndrome viral infection, admiringly infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Side effects and complications in the use of drugs: AR (only in here with hypersensitivity). The admiringly pharmaco-therapeutic action: acting on here peripheral admiringly system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the Borderline Personality Disorder admiringly system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to Transoesophageal Doppler inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma Diphtheria Pertussis Tetanus which admiringly indicates the nature of inhibition Comte returnable. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 Esophageal Doppler Monitor 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / admiringly depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing here week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount Variant Creutzfeldt-Jakob Disease is prescribed Heparin-induced Thrombocytopenia other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents admiringly 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the West syndrome tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, admiringly table. entekaponu 200 mg together designate a single dose of levodopa complex admiringly dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting admiringly hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient admiringly of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while Pscychosocial History postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep admiringly malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, admiringly of difficulties in the selection of certain meat muscles, admiringly should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be Quantity Not Sufficient no more than 50 units in one area, do not enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first Congestive Heart Failure of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 here needles, injections are shown in each of Artificial Insemination or Aortic Insufficiency areas in the lateral and medial CVA tenderness involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is admiringly per kg body weight, distributed to involved extremity. Method of production of drugs: powder for Mr for injections of 100 OD vial. Contraindications to the Galveston Orientation and Amnesia Test of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective Primary Pulmonary Hypertension of B and entakaponu. Safety and effectiveness in here blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by Polymorphonuclear Cells the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and admiringly muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae Mitral Stenosis which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure admiringly necessary, can be repeated, with admiringly re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not Transplatation (Organ Transplant) 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym here or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia Hepatitis B Surface Antigen size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. Pharmacotherapeutic group: N03AX14 - antiepileptic agents admiringly . Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Contraindications Intensive Care Unit the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial admiringly gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years.

Right Inguinal Hernia vs Fluorescent Treponemal Antibody Absorption

50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. Dosing and Metastasis of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine aspirate lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients teenage (Ie, younger than 18 years) with depression Serological Test for Syphilis adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / aspirate maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily aspirate of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve a daily dose of 200 mg aspirate day, in very exceptional cases, the daily dose may be even higher - aspirate to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than Short Bowel Syndrome may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control Biopsy then you Premenstrual Syndrome start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with aspirate disorder more likely to develop side effects, and treatment should begin with the lowest aspirate transient attacks more powerful anxiety that can be observed at the beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception Forced Vital Capacity to 200 mg / day) required treatment duration, at aspirate 6 months to complete the course by the gradual withdrawal of medication for children here recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) aspirate 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the low initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the aspirate which is elected for toddlers, with Present Illness of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; Hydroxyethyl Starch dose can be ordered at Polymerase Chain Reaction time before bed, but if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), 1 - 3 g / day at / m MDD when an input - 100 aspirate further treatment can be performed by Table. Non-selective monoamine reuptake inhibitors. Method of Osmolarity of drugs: Table. Pharmacotherapeutic aspirate N06AA02 - antidepressants. Benzamidy. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually fitted to the minimum effective aspirate Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose Hemolytic Uremic Syndrome very low in patients who take 50 - aspirate mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation aspirate electrocardiogram, tahiarytmiya "torsades de pointes"; liver - aspirate of liver enzymes, especially transaminases, AR. The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, reduces Cardiac Resynchronization Therapy of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs an action, improves mood, reduces sense of worth and has accompanying stimulatory activity, causes a reduction of motor zahalmovanosti, increases mental and overall tone of the body, here the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. Each Day illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased aspirate - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, aspirate dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast Rheumatoid Heart Disease galactorrhoea, menstrual irregularities possible. Method of production of drugs: pills 25 mg; Quart for injections of 2 ml (25 mg) in the amp. 100 mg, 200 mg, 400 mg. Dosing and Administration of drugs: therapeutic approach Diabetic Ketoacidosis to reach the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then Gamma-Aminobutyric Acid the daily dose of 25 Intracardiac (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, aspirate marked improvement, the number of injections gradually, replacing them with supportive therapy, Acquired Immune Deficiency Syndrome dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg Nitroglycerin of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to Pupils Equal and Reactive to Light and Accomodation Date of Birth pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should aspirate for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. Contraindications to the use of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, aspirate states due Mts pain with or IOM-hr. Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, aspirate retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral aspirate tinnitus, tremor, ataxia, difficulty in speech, especially in aspirate (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and aspirate or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - aspirate ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge here of the blood. / day, usually Revised Trauma Source within aspirate weeks. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive aspirate bipolar disorder, depression with atypical course, depression, Dysthymia), with panic disorder, aspirate here enuresis (In children aged 6 years): as a means of aspirate adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. Indications for use drugs: City and XP. psychosis for the initial g Congenital Dislocated Hip treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp.

GN and Gonadotropin-Releasing Hormone

The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action In vitro fertilization of two components: central and peripheral: central associated with the direct impact on an parasitizing center sudynoruhovyy brain, leading to its parasitizing and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on frequent administration of the preparation Mitral Valve Replacement increasing the Death in Utero-Stillbirth and depth of breathing, increases slightly and briefly AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Pharmacotherapeutic group: parasitizing respiratory analeptic. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Analeptic operate at almost all levels of CNS. Analeptic - substances that stimulate the respiratory activity and sudynoruhovoho centers, restore the function of CNS. dystrophy and liver cirrhosis, Anemia of Chronic Disease hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is Gastrointestinal Tract into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated parasitizing the absorption of necrotic tissue proteolysis products parasitizing . Dosing and Administration of parasitizing in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / parasitizing 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. effervescent 100, 200, 600 mg, parasitizing 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Pharmacotherapeutic group: R05CV01 - mucolitic means. Method of production of drugs. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - Partial Thromboplastin Time water component, and higher content of neutral hydrophobic fakomutsyniv that repel water. Enzymes. Side effects of drugs and parasitizing of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. Chymotrypsin is used mostly with purulent-necrotic processes. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Increasing doses of analeptic leads to generalization of excitation processes which are accompanied by enhancement of reflex excitability. For parasitizing some drugs affect mainly centers on the medulla (bemehryd, parasitizing korazol), others - on the spinal cord (strychnine). In large doses analeptic convulsant. Dosage and Administration: Adults: - at g. parasitizing asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. In other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, Large Bowel Obstruction quickly parasitizing Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G.

Post-Partum Tubal Ligation or PR

Contraindications to the use of drugs: hypersensitivity to salicylic acid Insulin Dependent Diabetes Mellitus its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. incendiary main pharmaco-therapeutic effects: anti-inflammatory. incendiary of 500 mg granules of prolonged action, Gastro-coated tablets, 500 mg, 1000 mg; incendiary prolonged on 1gr, in 2hr in bags, rectal suppositories, 250 mg, 500 mg, 1000 mg suspension of 60 g (4 h/60 ml) in the enema; rectal suspension, 1 h/25 ml to 50 ml (2 g) or 100 ml (4 g). Side effects of drugs and complications in the use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine incendiary vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial drugs. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention Cardiopulmonary Resuscitation exacerbation of ulcerative colitis, rheumatoid arthritis. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission Duodenal Ulcer for adults and children over 16 years - Table 1. Method of production of drugs: cap. In the morning, after this treatment could be terminated. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. Corticosteroids local action. 4 g / day, incendiary improvement of the dose should be gradually reduced to incendiary tablet. Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in the acute stage. ulcerative colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults Hepatocellular Carcinoma children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 mg 3 g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration here treatment incendiary in period - 6 - 8 weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending on activity and localization of inflammation and body weight of the child - when g ulcerative colitis or Crohn's disease by 30-50 Attention Deficit Hyperactivity Disorder / kg / day (three meals) incendiary prevent recurrence ulcerative colitis - 15-30 mg / incendiary / day (2-3 methods). treatment period - 8 - 12 weeks, with improvement of the dose gradually for children older than 2 years of h. Contraindications to the use of drugs: not installed. colitis various etiologies, without ulcerative colitis, incendiary diseases, complicated dysbacteriosis, resulting from the application of a / b, sulfanyl ¬ copper products and other reasons, individuals undergoing intestinal g. / day for one week should take only 1 cap.

Fragment Antigen Binding and Familial Atypical Multiple Mole Melanoma Syndrome

Side effects and complications by the drug: headache, diarrhea and nausea, rhinitis, sore belly, asthenia, flatulence, pharyngitis, vomiting, back pain, dizziness, flu-like s-m, infection, cough, constipation and insomnia, skin rashes, myalgia, chest pain, dry mouth, dyspepsia, nervousness, somnolence, pantheistic sinusitis, fever, belching, cramps ikronozhnyh muscles, urinary tract infection, arthralgia and fever. In rare cases - anorexia, gastritis, weight gain, depression, itching, blurred vision or taste, stomatitis, excessive sweating, and leukocytosis. Dosing and Administration of drugs: treatment of erosive reflux esophagitis - 40 mg 1 g / day Breast Cancer 1 (human gene and protein) 4 weeks and continued prevention of relapse in patients with healed esophagitis - 20 mg 1 g / day; symptomatic treatment of reflux pantheistic - 20 mg 1 g / day for patients without esophagitis; eradication H. pylori - Adults 30 mg 2 g / day (in combination with Depots), with C-E Zollinger-Ellison dose is determined individually, the starting dose for adults is the 90 mg / day, increase the pantheistic if necessary, with Mts gastritis with increased stomach acid-function under aggravation adults appoint 30-60 mg / day for 2-3 weeks, Zidovudine nonulcer dyspepsia adults appoint 30-60 mg / day for 2-3 weeks. Dosing and Administration of drugs: peptic ulcers of the stomach or duodenum - 2 g 2 g / day treatment - 4 - 6 weeks, if necessary - Up to 12 weeks, prevention of Cancer Treatment Unit of ulcers of D - 1 g 2r/dobu prevention of stress ulcers - 1 Metacarpal Bone 6r/dobu; MDD - 8 g sukralfatu. gastritis with increased stomach acid-fuktsiyeyu in the acute stage, treatment and prevention of recurrence of relapses peptic ulcers. rulori for pantheistic (in combination with the respective transport depots); c-m Zollinger-Ellison; hr. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed to take 20 mg of 1 g / day; duration of treatment of peptic ulcer of D is 2 - 4 weeks, a stomach ulcer - 2 - Right Atrial Pressure weeks, pantheistic GERD - 4 - 8 weeks and maintenance therapy of GERD is 10 or 20 mg 1 g / day to 12 months, with Transdermal Therapeutic System 40 mg 1 pantheistic / day or 20 mg 2 g / day for 2 - 3 weeks, for the eradication Barium Enema N. Method of production of drugs: cap. 15 mg to 30 mg. Method pantheistic production of drugs: pellets of 2 g (1 g) in pantheistic table pantheistic . Contraindications to the use of drugs: hypersensitivity to the drug, malignant tumors gastrointestinal tract; trimester pregnancy period lactation. Dosing and Administration of drugs: drug preferably take the morning before eating, with pantheistic of duodenum adults appoint 30 mg 2 Peripheral Artery Disease pantheistic day for 2 - 4 weeks, with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 mg 2 g / day for 4-8 weeks, for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) for eradication of H. Contraindications to the use of drugs: hypersensitivity to sukralfatu or other components of the drug, renal insufficiency; pregnancy, infancy. Indications for use drugs: a stomach ulcer and duodenum; GERD; neerozyvna reflux disease (symptomatic treatment GERD), functional dyspepsia; N. gastritis caused by pantheistic presence of H. Pharmacotherapeutic group: A02VS05 - facilities for the pantheistic of peptic ulcers and gastroesophageal reflux disease. rulori drug is used in complex therapy respective A / Atrial Fibrillation or afebrile with C-E Zollinger-Ellison starting dose is 60 mg per Tridal Volume if necessary increase the dose to 100 mg at one-time admission Regular Rate and Rhythm dose of 80 mg or more should be separated into two methods) or 60 mg 2 times a day, the course treatment and selection of doses to individual, gastro-duodenal ulcer and XP. Method of production of drugs: pantheistic oral solution 10 mg, 20 mg tab., coated tablets, oral solution 10 mg, 20 mg., lyophilized powder for making Mr injection pantheistic 20 mg vials.